Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) was added and the prior notices about government funding and operating status were removed, reflecting minor site-wide text updates to banners and version labeling. No impact on study data, outcomes, or core page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with links to cc.nih.gov and opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check28 days agoChange DetectedThe history page now includes a 'Show glossary' option, color-coded additions and deletions, and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedNew page revision label v3.3.4 was added and the previous v3.3.3 label removed; this is a minor UI update with no impact on study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new revision entry: v3.3.3 in the study history. The footer now removes the HHS Vulnerability Disclosure and the older Revision: v3.3.2 entry.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history shows an added revision entry v3.3.2 and removal of v3.3.1, indicating a minor UI/version-labeling update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.